[HTML][HTML] The HDAC6 inhibitor trichostatin A acetylates microtubules and protects axons from excitotoxin-induced degeneration in a compartmented culture model
K Hanson, N Tian, JC Vickers, AE King - Frontiers in Neuroscience, 2018 - frontiersin.org
Axon degeneration has been implicated as a pathological process in several
neurodegenerative diseases and acquired forms of neural injury. We have previously shown …
neurodegenerative diseases and acquired forms of neural injury. We have previously shown …
[HTML][HTML] Inducing chronic excitotoxicity in the mouse spinal cord to investigate lower motor neuron degeneration
CA Blizzard, KM Lee, TC Dickson - Frontiers in neuroscience, 2016 - frontiersin.org
We report the methodology for the chronic delivery of an excitotoxin to the mouse spinal cord
via surgically implanted osmotic mini-pumps. Previous studies have investigated the effect of …
via surgically implanted osmotic mini-pumps. Previous studies have investigated the effect of …
Pharmacogenetics at 50: genomic personalization comes of age
TJ Urban, DB Goldstein - Science translational medicine, 2014 - science.org
The study of the genetics of drug responses has a long history but has provided only a few
examples of gene variants that are relevant clinically. Here, we discuss the current state of …
examples of gene variants that are relevant clinically. Here, we discuss the current state of …
Polyfluorinated scaffolds in drug discovery
F Pertusati, M Serpi, E Pileggi - Fluorine in Life Sciences: Pharmaceuticals …, 2019 - Elsevier
The introduction of fluorine in drug-like compounds is now a well-accepted and very efficient
strategy in drug discovery, encouraged by the extensive synthetic methodologies available …
strategy in drug discovery, encouraged by the extensive synthetic methodologies available …
Assisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program
GE Lancioni, IL Simone, MF De Caro… - …, 2015 - content.iospress.com
BACKGROUND: Eye-tracking communication devices and brain-computer interfaces are the
two resources available to help people with advanced amyotrophic lateral sclerosis (ALS) …
two resources available to help people with advanced amyotrophic lateral sclerosis (ALS) …
[HTML][HTML] Gacyclidine improves the survival and reduces motor deficits in a mouse model of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder typified by a
massive loss of motor neurons with few therapeutic options. The exact cause of neuronal …
massive loss of motor neurons with few therapeutic options. The exact cause of neuronal …
Pharmacogenetics of neurodegenerative disorders
R Cacabelos, C Torrellas, P Cacabelos… - … and Predictive Genetics …, 2015 - Springer
Abstract Neurodegenerative disorders (NDDs)(Alzheimer's disease, Parkinson's disease,
amyotrophic lateral sclerosis, multiple sclerosis, Huntington's disease) represent a major …
amyotrophic lateral sclerosis, multiple sclerosis, Huntington's disease) represent a major …
A basic technology-aided programme for leisure and communication of persons with advanced amyotrophic lateral sclerosis: performance and social rating
Purpose: This study assessed (a) the impact of a technology-aided programme on the
leisure and communication engagement of persons with advanced amyotrophic lateral …
leisure and communication engagement of persons with advanced amyotrophic lateral …
[PDF][PDF] Disease modifying treatment of amyotrophic lateral sclerosis
RB Choudry, N GalvezJimenez… - … .[Oppdatert 18. mar, 2015 - cmapspublic3.ihmc.us
Disease modifying treatment of amyotrophic lateral sclerosis All topics are updated as new
evidence becomes availa Page 1 05/02/2018 Disease modifying treatment of amyotrophic …
evidence becomes availa Page 1 05/02/2018 Disease modifying treatment of amyotrophic …
Investigating pharmacological and non-pharmacological therapeutic approaches in Amyotrophic Lateral Sclerosis
S Tsitkanou - 2021 - dro.deakin.edu.au
This thesis investigated the effects of pharmacological and non-pharmacological therapeutic
approaches on skeletal muscle health and disease progression in a novel mouse model …
approaches on skeletal muscle health and disease progression in a novel mouse model …